ECCMID 2019: Day 3 update

0

Video highlights

Remember you can find us at booth #1.7d, or follow out Twitter updates @IDHubFSG

Today’s news

Pick of the Posters

1. Fluoroquinolone use and the risk of acute liver injury, by Nibell O from Lund University, conducted a registry based cohort study in a Swedish setting in order to assess whether oral fluoroquinolone use was associated with liver injury, discovering a more than six-fold risk of acute liver injury associated with oral fluoroquinolone use. The increased risk was most prominent during the first month after the start of treatment and seemed to decrease over time.

2. Neisseria gonorrhoeae antimicrobial resistance in Spain. Should we keep using azithromycin for empirical treatment? by Salmerón P form the Universitari Vall d’Hebron, carried out a muticenter study of nine hospitals in Spain, testing the susceptibility of gonorrhoea isolates obtained from patients. The authors concluded that gonorrhoea susceptibility to extended-spectrum cephalosporin remains high, however, the increased rate of azithromycin resistance (16%0 could threaten dual therapy, thus a surveillance program for the correct management of gonorrhoea should be developed.

Best of social media #ECCMID19

Share:

Leave A Comment